Moberg Pharma's Interim Report to be Published on February 1
STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- On February 11th, 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for July - December 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.
The teleconference will be hosted by Moberg Pharmas's CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English.
Date: February 11th, 2020
Time: 3:00 pm (CET)
To participate in the conference, please dial in on any number below before the start of the call:
The quarterly report and other information material will be made public on:
For additional information, please contact:
Anna Ljung, CEO, Phone: + 46-70-766-60-30, e-post: [email protected]
Mark Beveridge, VP Finance, Phone: + 46-76-805-82-88, e-post: [email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Moberg Pharma's Interim report for July - December 2019 to be published on February 11 - Invitation to teleconference
SOURCE Moberg Pharma